{
  "trial_id": "NCT01891344",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG performance status, histological subtype, number of prior chemotherapy regimens, BRCA mutation status, presence of measurable disease, prior cancer history, prior PARP inhibitor treatment, presence of central nervous system metastases, gastrointestinal disorders, hospitalization history for bowel obstruction.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Number of Prior Chemotherapy Regimens",
          "number of prior chemotherapy regimens"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Number of Prior Platinum Regimens",
        "Platinum Sensitivity Status"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "ECOG performance status",
        "histological subtype",
        "BRCA mutation status",
        "presence of measurable disease",
        "prior cancer history",
        "prior PARP inhibitor treatment",
        "presence of central nervous system metastases",
        "gastrointestinal disorders",
        "hospitalization history for bowel obstruction."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Histological subtype, Number of prior chemotherapy regimens, Presence of measurable disease, gBRCA mutation status,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Number of Prior Chemotherapy Regimens",
          "Number of prior chemotherapy regimens"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "Number of Prior Platinum Regimens",
        "Platinum Sensitivity Status"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Histological subtype",
        "Presence of measurable disease",
        "gBRCA mutation status"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Eastern Cooperative Oncology Group (ECOG) Performance Status, Histology, Grade, Number of prior chemotherapy regimens, Time from last chemotherapy, Best response to last chemotherapy, Presence of measurable disease, Presence of biopsiable disease, gBRCA mutation status, Prior platinum sensitivity.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Number of Prior Chemotherapy Regimens",
          "Number of prior chemotherapy regimens"
        ],
        [
          "Platinum Sensitivity Status",
          "Prior platinum sensitivity"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "Number of Prior Platinum Regimens"
      ],
      "remaining_candidate_features": [
        "Eastern Cooperative Oncology Group (ECOG) Performance Status",
        "Histology",
        "Grade",
        "Time from last chemotherapy",
        "Best response to last chemotherapy",
        "Presence of measurable disease",
        "Presence of biopsiable disease",
        "gBRCA mutation status"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), Eastern Cooperative Oncology Group (ECOG) performance status, histological subtype, grade of cancer, number of prior chemotherapy regimens, time since last chemotherapy, presence of measurable disease, presence of biopsiable disease, gBRCA mutation status, prior cancer history, presence of central nervous system metastases, presence of gastrointestinal disorders.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Number of Prior Chemotherapy Regimens",
          "number of prior chemotherapy regimens"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Number of Prior Platinum Regimens",
        "Platinum Sensitivity Status"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "body mass index (BMI)",
        "Eastern Cooperative Oncology Group (ECOG) performance status",
        "histological subtype",
        "grade of cancer",
        "time since last chemotherapy",
        "presence of measurable disease",
        "presence of biopsiable disease",
        "gBRCA mutation status",
        "prior cancer history",
        "presence of central nervous system metastases",
        "presence of gastrointestinal disorders."
      ]
    }
  }
}